Image

    Alopecia Universalis: An Extremely Rare but Probable Adverse Effect of Adalimumab

    January 2014 in “ IOSR journal of pharmacy ”
    Pooja Kadam, Prashant Kaushik
    Studysummary This case report identifies alopecia universalis as a probable adverse drug reaction to adalimumab in a patient with psoriasis and psoriatic arthritis.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on doi.org →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Alopecia Universalis During Treatment with Leflunomide and Adalimumab: Case Report Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia · 2014
    2. Overview of Alopecia Areata ˜The œjournal of investigative dermatology. Symposium proceedings/˜The œJournal of investigative dermatology symposium proceedings · 2013
    3. Renbök Phenomenon in a Patient With Alopecia Areata Universalis Archives of dermatology · 2012